jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Indian Journal of Pharmacy PracticeNOW IN
Article

Pyrazinamide-induced Polyarthralgia and Myalgia in a Case of Stable Chronic Kidney Disease

Bijoy Kumar Panda1, Vaibhav Rajendra Suryawanshi1, Medha Bargaje2, Sathiyanarayanan L3★★ Corresponding author

  1. 1Department of Clinical Pharmacy, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune, Maharashtra, INDIA.
  2. 2Department of Pulmonary Medicine, Bharati Vidyapeeth (Deemed to be University) Medical College and Hospital, Pune, Maharashtra, INDIA.
  3. 3Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune, Maharashtra, INDIA.

CORRESPONDENCE

Sathiyanarayanan L

Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune, Maharashtra, INDIA.

l.satyanarayan@bharatividyapeeth.edu

Volume 15, Issue 1 · pp. 49–52 · PUBLISHED · DOI: 10.5530/ijopp.15.1.10

View on IJPP original site ↗

ABSTRACT

Pyrazinamide is known to cause hyperuricemia and is followed by gout arthritis. But the fate of this drug in chronic kidney disease (CKD) patients is still not explored in details yet. We report a case of a 65-year-old Asian-Indian woman who was diagnosed with stable CKD 5 years ago and is currently diagnosed with peritoneal tuberculosis with pleural effusion. She was started on antitubercular therapy (ATT). On the 11th day of ATT, she developed a rise in uric acid (from 7.2 mg/dL to 13.1 mg/dL) and creatine kinase levels (from 156 U/L to 887 U/L), followed by polyarthralgia and generalised myalgia on investigation. Her elevated uric acid and creatine kinase levels and polyarthralgia improved on cessation of pyrazinamide, but improvement in her myalgia and muscle weakness was postponed. Pyrazinamide plasma 2 hr levels post dose was performed suspecting polyarthralgia and myalgia as an adverse drug reaction and estimated to be 59 μg/ml (normal range: 20-50 μg/ml). Subjective and objective assessments along with pyrazinamide plasma levels may be an indicative evidence of the adverse reaction as the estimated plasma concentration at 2 hr was higher than the normal range.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Panda, B. K., Suryawanshi, V. R., Bargaje, M., & L, S. (). Pyrazinamide-induced Polyarthralgia and Myalgia in a Case of Stable Chronic Kidney Disease. Indian Journal of Pharmacy Practice, 15(1), 49–52. https://doi.org/10.5530/ijopp.15.1.10